These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7768988)

  • 1. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA; Wright JA
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J; Hurta RA
    Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early induction of ribonucleotide reductase gene expression by transforming growth factor beta 1 in malignant H-ras transformed cell lines.
    Hurta RA; Samuel SK; Greenberg AH; Wright JA
    J Biol Chem; 1991 Dec; 266(35):24097-100. PubMed ID: 1748682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J; Buick RN
    Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).
    Burton TR; Kashour T; Wright JA; Amara FM
    Int J Oncol; 2003 Jan; 22(1):21-31. PubMed ID: 12469181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
    Amara FM; Smith GM; Kuschak TI; Takeuchi TL; Wright JA
    Biochem Biophys Res Commun; 1996 Nov; 228(2):347-51. PubMed ID: 8920917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells.
    Kim ES; Kim MS; Moon A
    Cytokine; 2005 Jan; 29(2):84-91. PubMed ID: 15598443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
    Haddow S; Fowlis DJ; Parkinson K; Akhurst RJ; Balmain A
    Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
    Wisdom R; Huynh L; Hsia D; Kim S
    Oncogene; 2005 Oct; 24(47):7043-54. PubMed ID: 16007133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
    Longstreet M; Miller B; Howe PH
    Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells.
    Hurta RA; Huang A; Wright JA
    J Cell Biochem; 1996 Mar; 60(4):572-83. PubMed ID: 8707896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
    Serra R; Verderame MF; Isom HC
    Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy.
    Wright JA; Turley EA; Greenberg AH
    Crit Rev Oncog; 1993; 4(5):473-92. PubMed ID: 8241321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.